De la corticothérapie classique à l'assaut cortique. RencontreAnnales de médecine interne (Paris). 1994, Vol 145, pp 1-47, issn 0003-410X, 46 p., SUP2Conference Proceedings

Theoretical study of C₃, C₃^- and C₃⁺RAGHAVACHARI, K.Chemical physics letters. 1990, Vol 171, Num 3, pp 249-253, issn 0009-2614, 5 p.Article

De la corticothérapie classique à l'aasaut cortisonique = From classical corticosteroid therapy to cortisone loadingARLET, J.Annales de médecine interne (Paris). 1994, Vol 145, pp 5-10, issn 0003-410X, SUP2Conference Paper

Pharmacocinétique clinique des corticoïdes = Clinical pharmacokinetics of corticosteroidsCHOSIDOW, O; HERSON, S.Annales de médecine interne (Paris). 1994, Vol 145, pp 19-21, issn 0003-410X, SUP2Conference Paper

Corticothérapie en pneumologie = Corticosteroid therapy in pneumologyMUIR, J.-F; BENHAMOU, D.Annales de médecine interne (Paris). 1994, Vol 145, pp 34-36, issn 0003-410X, SUP2Conference Paper

Corticoïdes et sclérose en plaques = Corticosteropids and multiple sclerosisDEFER, G; CESARO, P; DEGROS, J.-D et al.Annales de médecine interne (Paris). 1994, Vol 145, pp 37-41, issn 0003-410X, SUP2Conference Paper

Corticothérapie et traumatisme médullaire = Corticotherapy and medullary traumaGRAFTIEAUX, J.-P; BERTAULT, R; GOMIS, P et al.Annales de médecine interne (Paris). 1994, Vol 145, pp 42-47, issn 0003-410X, SUP2Conference Paper

Glomérulopathies à C3 = C3 glomerulopathyCHAUVET, Sophie; SERVAIS, Aude; FREMEAUX-BACCHI, Véronique et al.Néphrologie & thérapeutique. 2014, Vol 10, Num 2, pp 78-85, issn 1769-7255, 8 p.Article

La corticothérapie au cours des maladies systématiques = Corticosteroid therapy in systemic diseasesCOHEN, P; GUILLEVIN, L.Annales de médecine interne (Paris). 1994, Vol 145, pp 23-28, issn 0003-410X, SUP2Conference Paper

Actes du deuxième colloque C3, Angoulême, 20-22 mai 1987 = Proceedings of the second workshop C3, Angoulème, May 20-22, 1987ARNOLD, A.Colloque C3. 2. 1987, 397 p.Conference Proceedings

Alkylation des C3/C4 = C3/C4 alkylationHELDER, Y.Pétrole et techniques. 1985, Num 314, pp 16-20, issn 0152-5425Article

Pseudosubluxación C2-C3 = Pseudosubluxation of C2-C3RODRIGUEZ VIVAS, C; MANGAS RAMIREZ, S; CANADAS ESPINOSA, F. J et al.Anales de pediatria (2003. Ed. impresa). 2010, Vol 73, Num 4, pp 211-212, issn 1695-4033, 2 p.Article

C3 alleles in diseases associated with C3 activationWELCH, T. R; BERRY, A.Disease markers. 1987, Vol 5, Num 2, pp 81-87, issn 0278-0240Article

HOMOZYGOUS C3 DEFICIENCY: DETECTION OF C3 BY RADIOIMMUNOASSAY.DAVIS AE III; DAVIS JS IV; RABSON AR et al.1977; CLIN. IMMUNOL. IMMUNOPATHOL.; U.S.A.; DA. 1977; VOL. 8; NO 3; PP. 543-550; BIBL. 25 REF.Article

Multiplicité des cibles immunologiques des corticoïdes = M%ultiplicity of the immunological targets of corticosteroidsYOUINOU, P; SIMON, I.Annales de médecine interne (Paris). 1994, Vol 145, pp 11-14, issn 0003-410X, SUP2Conference Paper

Modifications des lymphocytes circulants induites par la méthylprednisolone en bolus = Methylprednisolone bolus-induced modifications of circulating lymphocytesLE QUELLEC, A.Annales de médecine interne (Paris). 1994, Vol 145, pp 15-18, issn 0003-410X, SUP2Conference Paper

C3 DeficienciesBITTER-SUERMANN, D; BURGER, R.Current Topics in Microbiology and Immunology. 1990, Vol 153, pp 223-233, issn 0070-217XArticle

Human complement component C3: characterization of active C3 S and C3 F, the two common genetic variantsBEHRENDT, N.Molecular immunology. 1985, Vol 22, Num 8, pp 1005-1008, issn 0161-5890Article

Photosynthetic pathway-related ultrastructure of C₃,C₄ and C₃-like C₃-C₄ intermediate sedges (Cyperaceae), with special reference to EleocharisBRUHL, J. J; PERRY, S.Australian journal of plant physiology. 1995, Vol 22, Num 4, pp 521-530, issn 0310-7841Article

Immunoglobulinas e C₃ no granuloma paracoccidióidico = Immunoglobulines et complément C3 dans le granulome paracoccidioïdien = Immunoglobulins and C3 in the Paracoccidioides brasiliensis granulomaBIAGIONI, L. M. V; ORSI, S; CHAMMA, L. G et al.Revista do Instituto de Medicina Tropical de São Paulo. 1987, Vol 29, Num 2, pp 97-103, issn 0036-4665Article

Human complement component C3: characterization of active C3 S and C3 F, the two common genetic variantsBEHRENDT, N.Molecular immunology. 1985, Vol 22, Num 8, pp 1005-1008, issn 0161-5890Article

Persistently circulating C3 nephritic factor (C3 NeF)-stabilized alternative pathway C3 convertase (C3 CoF) in serum of an 11-year-old girl with meningococcal septicemia-simultaneous occurrence with free C3 NeFWAHN, V; MÜLLER, W; RIEGER, C et al.Pediatric research. 1987, Vol 22, Num 2, pp 123-129, issn 0031-3998Article

CLASSICAL PATHWAY ACTIVATION OF COMPLEMENT SYSTEM BY IGA ANTI-C3 ANTIBODY = ACTIVATION PAR LA VOIE CLASSIQUE DU SYSTEME DE COMPLEMENT PAR L'ANTICORPS IGA ANTI-C3WILLIAMS BD; SLANEY JM; PRICE JF et al.1976; NATURE; G.B.; DA. 1976; VOL. 259; NO 5538; PP. 52-53; BIBL. 7 REF.Article

KOMPLEMENTSPIEGEL BEI KINDERN MIT IDIOPATHISCH-NEPHROTISCHEM SYNDROM. (C3, C4 UND C3-AKTIVATOR). = LE TAUX DU COMPLEMENT CHEZ LES ENFANTS PRESENTANT UN SYNDROME NEPHROTIQUE IDIOPATHIQUE (C₃, C₄ ET ACTIVATEUR C₃)POLZ E; LUBEC G.1977; PAEDIATR. U. PAEDOL.; OESTERR.; DA. 1977; VOL. 12; NO 4; PP. 360-364; ABS. ANGL.; BIBL. 12 REF.Article

CAPPING OF THE LYMPHOCYTE C3 RECEPTOR AND TEMPERATURE-DEPENDENT LOSS OF C3 ROSETTES = FORMATION DE CALOTTES DE RECEPTEURS C3 LYMPHOCYTAIRES ET PERTE DES ROSETTES C3 DEPENDANT DE LA TEMPERATUREGORMUS BJ; SHANDS JW JR.1975; J. IMMUNOL.; U.S.A.; DA. 1975; VOL. 114; NO 4; PP. 1221-1225; BIBL. 16REF.Article